Literature DB >> 11401954

Tuberculosis: latency and reactivation.

J L Flynn1, J Chan.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11401954      PMCID： PMC98451          DOI： 10.1128/IAI.69.7.4195-4201.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  77 in total

1.  Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Authors:  R Maini; E W St Clair; F Breedveld; D Furst; J Kalden; M Weisman; J Smolen; P Emery; G Harriman; M Feldmann; P Lipsky
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

2.  In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta.

Authors:  C S Hirsch; J J Ellner; R Blinkhorn; Z Toossi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS).

Authors:  J E Graham; J E Clark-Curtiss
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes.

Authors:  M G Bonecini-Almeida; S Chitale; I Boutsikakis; J Geng; H Doo; S He; J L Ho
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

5.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  A mouse model of the recrudescence of latent tuberculosis in the elderly.

Authors:  I M Orme
Journal:  Am Rev Respir Dis       Date:  1988-03

7.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.

Authors:  J L Flynn; M M Goldstein; J Chan; K J Triebold; K Pfeffer; C J Lowenstein; R Schreiber; T W Mak; B R Bloom
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

8.  Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions.

Authors:  L G Wayne
Journal:  Am Rev Respir Dis       Date:  1976-10

9.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

Authors:  J D MacMicking; C Nathan; G Hom; N Chartrain; D S Fletcher; M Trumbauer; K Stevens; Q W Xie; K Sokol; N Hutchinson
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582
View more
  152 in total

Review 1.  Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary.

Authors:  Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

2.  Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Joanne Turner; Mercedes Gonzalez-Juarrero; Oliver C Turner; Ian M Orme
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 3.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

4.  The stringent response is required for full virulence of Mycobacterium tuberculosis in guinea pigs.

Authors:  Lee G Klinkenberg; Jong-Hee Lee; William R Bishai; Petros C Karakousis
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

5.  Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses.

Authors:  Wei Chen; Yige Bao; Xuerong Chen; Jeremy Burton; Xueli Gong; Dongqing Gu; Youjun Mi; Lang Bao
Journal:  Med Microbiol Immunol       Date:  2015-08-30       Impact factor: 3.402

6.  Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo CD62 ligand(hi) population.

Authors:  Andre Kipnis; Scott Irwin; Angelo A Izzo; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

7.  Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling.

Authors:  Adel M Talaat; Sarah K Ward; Chia-Wei Wu; Elizabeth Rondon; Christine Tavano; John P Bannantine; Rick Lyons; Stephen A Johnston
Journal:  J Bacteriol       Date:  2007-03-23       Impact factor: 3.490

8.  Replication dynamics of Mycobacterium tuberculosis in chronically infected mice.

Authors:  Ernesto J Muñoz-Elías; Juliano Timm; Tania Botha; Wai-Tsing Chan; James E Gomez; John D McKinney
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

9.  Crystallization and preliminary X-ray analysis of Rv1674c from Mycobacterium tuberculosis.

Authors:  Jincheng Li; Xudong Wang; Weimin Gong; Chunyan Niu; Min Zhang
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-02-28       Impact factor: 1.056

10.  Structure-based virtual screening and biological evaluation of Mycobacterium tuberculosis adenosine 5'-phosphosulfate reductase inhibitors.

Authors:  Sandro Cosconati; Jiyoung A Hong; Ettore Novellino; Kate S Carroll; David S Goodsell; Arthur J Olson
Journal:  J Med Chem       Date:  2008-10-15       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.